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An 80-year-old woman with rheumatoid arthritis had gait difﬁculties and frequent falls. MRI
of the brain showed an extra-axial enhancing lesion overlying the right frontal–parietal cor-
tex, that progressively extended to the contralateral side.This was accompanied by further
decline in her functional status. We discuss the diagnostic and therapeutic approach of a
pachy–leptomeningeal process in a rheumatoid patient.
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An 80-year-old woman presented to the neurology clinic with
a history of unsteady gait and frequent falls and was admitted
to our hospital for further evaluation. She had history of arte-
rial hypertension, chronic obstructive pulmonary disease, and
long-standing rheumatoid arthritis (RA) treated with prednisone
and plaquenil. In her youth, she had pulmonary tuberculosis
(TB) treated with streptomycin and para-aminosalicylic acid. Six
months prior to her clinic visit, she was admitted to a local hospital
for surgical treatment of a small bowel obstruction. Postopera-
tively, she developed atrial ﬁbrillation. She received intravenous
unfractionated heparin and then bridged to warfarin (target INR
2.0–3.0). While at the hospital, she fell and had a mild traumatic
subarachnoid hemorrhage (SAH). She made a good recovery and
was discharged home onwarfarin. Fourmonths following hospital
discharge, she fell again and had a left femoral fracture requiring
hip replacement.
Neurological examination showed a broad based unsteady gait.
A non-contrast head CT scan showed scattered dural and vascular
calciﬁcations. T2 weighted brain MRI showed an extra-axial high
signal intensity lesion overlying the right parietal–occipital region
with mild gyriform contrast enhancement (Figures 1A,B). There
were no signal abnormalities on T1 or gradient echo sequences. A
diagnosis of subacute post-traumatic SAH was made. She had suc-
cessful cardioversion, and was discharged home on amiodarone.
Five months later, she presented with worsening unsteadiness and
left sided weakness. Neurological examination showed impaired
left hand dexterity,mild weakness of the left leg, and a broad based
gait. Non-contrast head CT showed gyriform hyperdensity along
the lateral aspect of the right frontal cortex associated with sulcal
effacement. Gadolinium enhanced brain MRI showed an enhanc-
ing hyperintense signal abnormality overlying the right parietal
and posterior frontal lobes compatible with leptomeningeal and
dural thickening (Figures 2A,B). Cerebrospinal ﬂuid (CSF) analy-
sis showed 62 red blood cells (RBCs), 2 white blood cells (WBCs),
a glucose concentration of 60 mg/dl, and a protein content of
75 mg/dl. Cytology was negative for malignancy. HSV and VZV
PCRs in CSF were negative. CSF Lyme titer and cryptococcal anti-
gen were likewise negative. CSF VDRL was non-reactive. Viral,
bacterial, acid fast bacilli (AFB), and fungal cultures were nega-
tive in CSF and blood. Serum C-reactive protein was 2.9 mg/dl,
and erythrocyte sedimentation rate was 35 mm/h. Antinuclear
antibodies, anti-Smith, anti-ribonucleoprotein, anti-SSa, anti-SSb,
anti-histone, and SCL-70 were negative. Serum rheumatoid fac-
tor (RF) was <20. Serum angiotensin converting enzyme (ACE)
level was 10 U/L. Contrast CT scan of the chest, abdomen, and
pelvis showed lowdensity lesions throughout the spleen,and5 mm
nodules in lungs.
Symptoms progressed, and a follow-up gadolinium enhanced
MRI showed worsening of the right-sided leptomeningeal and
dural thickening as well as progression of the leptomeningeal
enhancement over the left posterior parietal and occipital lobes
(Figures 3A,B). A second lumbar puncture was performed. CSF
was clear with an opening pressure of 8 cm of H2O. There were
9 RBCs and 12 WBCs (78% lymphocytes). CSF glucose was
60 mg/dl, and the protein content was 77 mg/dl. Cytology was
again negative for malignant cells. Flow phenotyping showed
mixed lymphoid population, predominantly T-cells and occa-
sional B-cells, with no evidence of clonality. Bacterial, fungal, and
AFB cultures were negative in blood and CSF. Quantiferon gold
testing for TB was positive.
A brain/meningeal biopsy was done which showed a chronic
inﬂammatory process with numerous plasma cells with Rus-
sell bodies and granulomatous reaction of the leptomeninges
and dura. Findings were consistent with rheumatoid pachy
and leptomeningitis (Figures 4A,B). In addition, there was an
acute and chronic leptomeningitis with focal giant cell reac-
tion with secondary parenchymal perivascular lymphocytic inﬁl-
trates with reactive gliosis (Figures 5A–D). The leptomeninges
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FIGURE 1 | Extra-axial high signal intensity overlying the right parietal–occipital region with mild gyriform contrast enhancement.
FIGURE 2 | Hyperintense signal abnormalities overlying the right parietal and posterior frontal lobes with contrast enhancement, compatible with
dural and leptomeningeal thickening.
FIGURE 3 | Increased right-sided leptomeningeal and dural thickening with worsening of leptomeningeal enhancement over the left posterior parietal
and occipital lobes.
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FIGURE 4 | (A,B) Dura matter with chronic pachymeningitis.
FIGURE 5 | (A,B) Acute and chronic leptomenigitis. (C) Acute and chronic
leptomeningitis with giant cells. (D) Acute and chronic leptomeningitis with
secondary parenchymal perivascular lymphocytic inﬁltrates.
contained a focal abscess formation with suppurative inﬂamma-
tion (Figures 6A,B). Special stains including GMS, AFB, FITE,
Gram, and cultures were negative. Sections of the pachymenin-
gitis were sent for mycobacterium TB DNA PCR, and were also
negative.
DISCUSSION
Direct CNS involvement by inﬂammatory cells in RA, including
rheumatoid meningitis, is extremely rare (Bathon et al., 1989;
Chang and Paget, 1993; Voller et al., 2001; Bruggemann et al.,
2010).
FIGURE 6 | (A,B) Focal abscess formation.
Bathon et al. (1989) reviewed 19 patients (10 men and 9
women) with inﬂammatory rheumatoid CNS disease. Most cases
were diagnosed at autopsy. No MRI was performed. Most patients
had long-standing RA, with mean duration of illness of 14 years
at onset of neurological symptoms. Although rheumatoid CNS
involvement may occur during the phase of acute synovitis, less
than half of these patients had active synovitis when neurological
symptoms developed. The authors concluded that RA duration
and activity were unreliable indicators to diagnose rheumatoid
CNS involvement. However, rheumatoid meningitis may occur
early in the course of the disease and may even precede synovitis
(Jones et al., 2006; Starosta and Brandwein, 2007).
In Bathon’s review, the clinical presentation of rheumatoid
meningitis was characterized by altered mental status in 47%
of cases, cranial neuropathies in 26%, hemiparesis/paraparesis
in 21%, seizures in 21%, and headaches in 11%. Inﬂammatory
rheumatoid CNS disease may produce pachymeningitis and lep-
tomeningitis, as in the case of our patient (Bathon et al., 1989; Kato
et al., 2003; Jones et al., 2006; Shimada et al., 2009). If the duramat-
ter is predominantly affected, these patients present with pachy-
meningitis, characterized by headaches and cranial neuropathies
caused by inﬂammation or dural ﬁbrosis. If the leptomeninges
are predominantly affected,mental status changes, gait imbalance,
memory loss, depression, seizures, or paresis are more common
(Kupersmith et al., 2004).
Along with rheumatoid meningitis, Bathon identiﬁed other
extra-articular manifestations like subcutaneous nodules in 67%
of cases, visceral nodules in 47%, and both in 40%. Our patient
had lung and spleen nodules; these may have been a manifestation
of RA, or related to her previous TB.
Cerebrospinal ﬂuid ﬁndings in rheumatoid meningitis are vari-
able and often non-diagnostic (Kupersmith et al., 2004). Lympho-
cytic pleocytosis is not always present. An increased protein level
is frequently observed. However, sampling at points distant from
the lesion might produce pseudo negative results (Kato et al., 2003;
Kupersmith et al., 2004; Shimada et al., 2009). New speciﬁc mark-
ers are being identiﬁed. Determination of RF in CSF is often used
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as a diagnostic marker because strongly positive results speciﬁcally
indicate the disease (Kato et al., 2003). Inﬂammatory cytokines,
including TNF-α, IL-1β, and IL-6, play a central role in RA patho-
genesis and in some cases high CSF levels have been identiﬁed
in patients with rheumatoid meningitis, but their signiﬁcance is
still unknown (Kato et al., 2003; Shimada et al., 2009). Gadolin-
ium enhanced MRI is quite useful. Diffuse or patchy enhancing
extra-axial high intensity lesions in FLAIR and DWI, are consid-
ered characteristics of RA meningitis (Jones et al., 2006; Starosta
and Brandwein, 2007; Shimada et al., 2009).
The ﬁnal diagnosis is ultimately histopathological. In Bathon’s
review, rheumatoid meningitis diagnosis was not achieved until
autopsy in 17 of 19 patients. In two patients diagnosis was made
by open brain biopsy. On gross examination, thickened meninges
and nodules or plaques were observed frequently. Microscopic
pathological examination demonstrated three abnormal patterns:
rheumatoid nodules, non-speciﬁc meningeal inﬂammation, and
vasculitis. Nodules were the most common ﬁnding (68%) and
were histologically identical to subcutaneous rheumatoid nodules.
Nodules were located in the cranial meninges (92%) and in the
choroid plexus (15%). There were two cases affecting the spinal
meninges. Nodules were absent in the brain parenchyma or spinal
cord. Non-speciﬁc inﬂammatory inﬁltrates in the leptomeninges
or pachymeninges, with mononuclear cells, particularly plasma
cells, and less frequently necrosis and multinucleated giant cells,
was found in 63% of cases. Reasons for a meningeal predilection,
particularly the dura, rather than brain parenchyma, by invad-
ing inﬂammatory cells are unclear. Autoimmunity to collagen, a
major component of the dura but not brain parenchyma, may
play a role (Bathon et al., 1989). Vasculitis was identiﬁed in 37%
of cases and involved the brain, spinal cord parenchyma, as well as
the meninges. Vessel wall inﬁltrates consisted of lymphocytes and
plasma cells. The authors concluded that CNS rheumatoid nod-
ules might be considered speciﬁc for CNS rheumatoid disease.
In instances of non-speciﬁc chronic inﬂammatory inﬁltration by
vasculitis or meningitis the preponderance of plasma cells may
distinguish CNS rheumatoid disease from other connective tissue
disorders such as systemic lupus erythematosus (SLE) or Sjögren
syndrome. Among patients diagnosed at autopsy, the most com-
mon ﬁndings are rheumatoid nodules. Among patients diagnosed
by biopsy, it is a non-speciﬁc inﬂammatory inﬁltration, prob-
ably secondary to limited tissue sampling (Bathon et al., 1989;
Jones et al., 2006; Starosta and Brandwein, 2007; Li and Kuzuhara,
2009; Shimada et al., 2009). In our patient, biopsy showed chronic
inﬂammatory inﬁltration rich in plasma cells in both the pachy-
meninges and the leptomeninges. There was also a small focal
abscess even though cultures were negative. In Bathon’s report,
polymorphonuclear inﬁltrates were found in three patients (25%).
Although our patient had a positive quantiferonTB gold test, likely
due to her previous TB, AFB stains, cultures, and mycobacterium
TB DNA PCR were negative in the meningeal samples.
There are no clear guidelines for the treatment of rheumatoid
meningitis. Cyclophosphamide, azathioprine, andmethotrexate in
combination with corticosteroids have been recommended (Kato
et al., 2003; Kupersmith et al., 2004; Jones et al., 2006; Starosta and
Brandwein, 2007; Li and Kuzuhara, 2009; Shimada et al., 2009).
Improvement has been obtained with corticosteroids alone. This
suggests that immunosuppressants may not always be necessary in
the induction phase of treatment, although they may be required
to achieve tapering or cessation of corticosteroids to avoid poten-
tial long-term adverse effects (Shimada et al., 2009). Recurrence of
rheumatoid meningitis in a patient treated with inﬂiximab (Chou
et al., 2006) and pachymeningitis occurring after administration
of adalimumab have been reported (Ahmed et al., 2006).
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